drugset / Trial / NCT00845858
Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the safety and the effectiveness of two doses of metoclopramide nasal spray solution, 10 mg and 14 mg, compared to placebo in reducing the symptoms of diabetic gastroparesis.
Timeline
- Start
- 2009-04
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metoclopramide | Small molecule | 10 mg | Intranasal |
| Comparator | Metoclopramide | Small molecule | 14 mg | Intranasal |